ES2138672T3 - 6,7-epoxi-paclitaxeles. - Google Patents

6,7-epoxi-paclitaxeles.

Info

Publication number
ES2138672T3
ES2138672T3 ES95103435T ES95103435T ES2138672T3 ES 2138672 T3 ES2138672 T3 ES 2138672T3 ES 95103435 T ES95103435 T ES 95103435T ES 95103435 T ES95103435 T ES 95103435T ES 2138672 T3 ES2138672 T3 ES 2138672T3
Authority
ES
Spain
Prior art keywords
sup
alkyl
formula
alkynyl
cycloalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95103435T
Other languages
English (en)
Inventor
Gregory Roth
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Co
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Application granted granted Critical
Publication of ES2138672T3 publication Critical patent/ES2138672T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Inks, Pencil-Leads, Or Crayons (AREA)
  • Epoxy Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

LA PRESENTE INVENCION PROPORCIONA DERIVADOS DE PACLITAXEL DE FORMULA (I) EN LA QUE R1 ES -CORZ, DONDE RZ ES RR N-, RHN-, RO- O R; R2 ES ALQUILO C1-6, ALQUENILO C2-6, ALQUINILO C2-6, CICLOALQUILO C36, O UN RADICAL DE FORMULA -W-RX EN EL QUE W ES UN ENLACE, UN ALQUENODIILO C2-6 O -(CH2)T- SIENDO T DE 1 A 6; Y RX ES NAFTILO, FENILO O HETEROARILO, Y ADEMAS RX PUEDE SUSTITUIRSE OPCIONALMENTE POR UNO A TRES GRUPOS IGUALES O DISTINTOS DE ALQUILO C1-6, ALCOXI C1-6, HALOGENO O -CF3; R Y R PENDIENTEMENTE ALQUILO C1-6, ALQUENILO C2-6, CICLOALQUILO C3-6, ALQUINILO C2-6 O FENILO OPCIONALMENTE SUSTITUIDOS POR UNO A TRES GRUPOS IGUALES O DISTINTOS DE ALQUILO C1-6, ALCOXI C1-6, HALOGENO O -CF3. TAMBIEN SE DESCRIBEN EN ESTA INVENCION LAS FORMULACIONES (COMPOSICIONES) FARMACEUTICAS Y UN METODO PARA TRATAR TUMORES DE MAMIFEROS CON UN COMPONENTE DE LA FORMULA (I).
ES95103435T 1994-03-10 1995-03-09 6,7-epoxi-paclitaxeles. Expired - Lifetime ES2138672T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/212,468 US5395850A (en) 1994-03-10 1994-03-10 6,7-epoxy paclitaxels

Publications (1)

Publication Number Publication Date
ES2138672T3 true ES2138672T3 (es) 2000-01-16

Family

ID=22791154

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95103435T Expired - Lifetime ES2138672T3 (es) 1994-03-10 1995-03-09 6,7-epoxi-paclitaxeles.

Country Status (10)

Country Link
US (1) US5395850A (es)
EP (1) EP0671399B1 (es)
JP (1) JPH07285967A (es)
AT (1) ATE185808T1 (es)
AU (1) AU680587B2 (es)
CA (1) CA2143013A1 (es)
DE (1) DE69512811T2 (es)
DK (1) DK0671399T3 (es)
ES (1) ES2138672T3 (es)
GR (1) GR3032443T3 (es)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5380751A (en) * 1992-12-04 1995-01-10 Bristol-Myers Squibb Company 6,7-modified paclitaxels
US5500317A (en) * 1994-06-16 1996-03-19 Eastman Kodak Company Electrophotographic elements containing soluble cyclic sulfone electron transport agents
US5677470A (en) * 1994-06-28 1997-10-14 Tanabe Seiyaku Co., Ltd. Baccatin derivatives and processes for preparing the same
US5626862A (en) 1994-08-02 1997-05-06 Massachusetts Institute Of Technology Controlled local delivery of chemotherapeutic agents for treating solid tumors
CA2162759A1 (en) * 1994-11-17 1996-05-18 Kenji Tsujihara Baccatin derivatives and processes for preparing the same
GB2296239B (en) * 1994-12-21 1998-08-26 Erba Carlo Spa Taxane derivatives
US5840929A (en) * 1995-04-14 1998-11-24 Bristol-Myers Squibb Company C4 methoxy ether derivatives of paclitaxel
FR2732968B1 (fr) * 1995-04-14 1997-05-16 Rhone Poulenc Rorer Sa Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent
AU716005B2 (en) * 1995-06-07 2000-02-17 Cook Medical Technologies Llc Implantable medical device
US5635531A (en) * 1996-07-08 1997-06-03 Bristol-Myers Squibb Company 3'-aminocarbonyloxy paclitaxels
US5773464A (en) * 1996-09-30 1998-06-30 Bristol-Myers Squibb Company C-10 epoxy taxanes
US5912264A (en) * 1997-03-03 1999-06-15 Bristol-Myers Squibb Company 6-halo-or nitrate-substituted paclitaxels
CA2440935A1 (en) 2001-03-13 2002-09-19 Richard Liggins Micellar drug delivery vehicles and precursors thereto and uses thereof
US20030157170A1 (en) * 2001-03-13 2003-08-21 Richard Liggins Micellar drug delivery vehicles and precursors thereto and uses thereof
DE60220519T2 (de) * 2001-04-20 2007-09-27 The University Of British Columbia, Vancouver Mizellares arzneistoffverabreichungssystem für hydrophobe arzneistoffe
US20030216758A1 (en) * 2001-12-28 2003-11-20 Angiotech Pharmaceuticals, Inc. Coated surgical patches
AU2003300076C1 (en) 2002-12-30 2010-03-04 Angiotech International Ag Drug delivery from rapid gelling polymer composition
US8003122B2 (en) * 2004-03-31 2011-08-23 Cordis Corporation Device for local and/or regional delivery employing liquid formulations of therapeutic agents
US7846940B2 (en) * 2004-03-31 2010-12-07 Cordis Corporation Solution formulations of sirolimus and its analogs for CAD treatment
US7989490B2 (en) 2004-06-02 2011-08-02 Cordis Corporation Injectable formulations of taxanes for cad treatment
US20070073385A1 (en) * 2005-09-20 2007-03-29 Cook Incorporated Eluting, implantable medical device
US20070196423A1 (en) * 2005-11-21 2007-08-23 Med Institute, Inc. Implantable medical device coatings with biodegradable elastomer and releasable therapeutic agent
WO2008005284A2 (en) 2006-06-30 2008-01-10 Cook Incorporated Methods of manufacturing and modifying taxane coatings for implantable medical devices
US20080241215A1 (en) * 2007-03-28 2008-10-02 Robert Falotico Local vascular delivery of probucol alone or in combination with sirolimus to treat restenosis, vulnerable plaque, aaa and stroke
US8409601B2 (en) 2008-03-31 2013-04-02 Cordis Corporation Rapamycin coated expandable devices
US8420110B2 (en) 2008-03-31 2013-04-16 Cordis Corporation Drug coated expandable devices
US8273404B2 (en) * 2008-05-19 2012-09-25 Cordis Corporation Extraction of solvents from drug containing polymer reservoirs
US8642063B2 (en) * 2008-08-22 2014-02-04 Cook Medical Technologies Llc Implantable medical device coatings with biodegradable elastomer and releasable taxane agent
US9198968B2 (en) 2008-09-15 2015-12-01 The Spectranetics Corporation Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens
US20120303115A1 (en) 2011-05-25 2012-11-29 Dadino Ronald C Expandable devices coated with a rapamycin composition
US20120302954A1 (en) 2011-05-25 2012-11-29 Zhao Jonathon Z Expandable devices coated with a paclitaxel composition
US9956385B2 (en) 2012-06-28 2018-05-01 The Spectranetics Corporation Post-processing of a medical device to control morphology and mechanical properties
DE102015000626A1 (de) * 2015-01-22 2016-07-28 Kibion Gmbh Verfahren zum Nachweis von Helicobacter Pylori
AU2016326747A1 (en) 2015-09-25 2018-03-01 Zy Therapeutics Inc. Drug formulation based on particulates comprising polysaccharide-vitamin conjugate

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5227400A (en) * 1991-09-23 1993-07-13 Florida State University Furyl and thienyl substituted taxanes and pharmaceutical compositions containing them
US5254580A (en) * 1993-01-19 1993-10-19 Bristol-Myers Squibb Company 7,8-cyclopropataxanes
CA2109861C (en) * 1992-12-04 1999-03-16 Shu-Hui Chen 6,7-modified paclitaxels

Also Published As

Publication number Publication date
ATE185808T1 (de) 1999-11-15
AU1479595A (en) 1995-09-21
EP0671399A1 (en) 1995-09-13
JPH07285967A (ja) 1995-10-31
CA2143013A1 (en) 1995-09-11
DE69512811T2 (de) 2000-06-15
GR3032443T3 (en) 2000-05-31
AU680587B2 (en) 1997-07-31
EP0671399B1 (en) 1999-10-20
US5395850A (en) 1995-03-07
DK0671399T3 (da) 1999-12-27
DE69512811D1 (de) 1999-11-25

Similar Documents

Publication Publication Date Title
DK0671399T3 (da) 6,7-epoxypaclitaxel
MEP24608A (en) Azetidine derivatives, preparation thereof and pharmaceutical compositions containing same
BG92804A (bg) 4-бензоилизоксазолови производни
DK0600517T3 (da) 6,7-modificerede paclitaxeler.
ATE217305T1 (de) Desoxy-taxol-derivate
SE8302130L (sv) Farmakologiskt aktiva bifosfonater, forfarande for deras framstellning och farmaceutiska kompositioner innehallande desamma
FI914163A0 (fi) Heterocykliska derivat.
CY1108313T1 (el) Παραγωγα της κινολινης και η χρηση τους ως προσδεματων 5-ht6
RU94040390A (ru) Производные виниленазаиндола, способ их получения, фармацевтическая композиция
YU40997A (sh) Novi oksadiazoli, postupci za njihovo pripremanje
PT992509E (pt) Novos derivados macrolidos
MD502G2 (ro) Derivaţi noi ai adenozinei, procedee de preparare a lor, compoziţii farmaceutice ce le conţin
IL95762A0 (en) Benzanilides,their preparation and pharmaceutical compositions containing the same
ATE250586T1 (de) Imidazoline derivate,ihre herstellung und pharmazeutische zusammensetzungen die sie enthalten
ES2099180T3 (es) Derivados del benzopirano y procedimientos para su preparacion.
KR890000406A (ko) 신나모일아미드 유도체, 그들의 제조방법, 그들을 함유하는 제약학적 조성물 및 그들의 사용
NO164474C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive heksahydropyrrolo(2,1-a)isokinolin-derivater.
IL115085A0 (en) Bicyclic carboxamide derivatives their preparation and pharmaceutical compositions containing them
PL297368A1 (en) Novel derivatives of 2h-benzo (b) pyrane substituted with aryl or n-heteroaryl at position 4, method of obtaining them and their applications as well as preparation containing these compounds
FR2674246B1 (fr) Nouveaux derives de l'acide alpha-methylene 5-thiazolacetique, leur procede de preparation et les intermediaires de ce procede, leur application a titre de fongicides et les compositions les renfermant.
FR2653124B1 (fr) Nouveaux derives substitues en 15 de la 20, 21-dinoreburnamenine, leur procede de preparation et les nouveaux intermediaires ainsi obtenus, leur application comme medicaments et les compositions les renfermant.
AR015298A1 (es) Compuestos derivados aciclicos de carboxamida carboxi-sustituidos, particularmente utiles como antagonistas de receptores de taquiquininas, composicion farnaceutica y uso en la fabricacion de una composicion farmaceutica para tratar asma.
DK168284D0 (da) Troponderivater
DE69533833D1 (de) Verfahren zur Herstellung von Indolopyrrolocarbazol-Derivaten
DE68909961D1 (de) 2-Aminoacetamid Derivate.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 671399

Country of ref document: ES